Hot Diversified Bank Companies To Buy Right Now: Insmed Inc.(INSM)
Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.
Advisors' Opinion:- [By CRWE]
Insmed Incorporated (Nasdaq:INSM), a biopharmaceutical company, recently reported that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE庐 (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.
source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-diversified-bank-companies-to-buy-right-now-2.html
No comments:
Post a Comment